Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
1.030
0.00 (0.00%)
At close: Jul 11, 2025, 4:00 PM
1.030
0.00 (0.00%)
After-hours: Jul 11, 2025, 8:00 PM EDT

MTNB Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
5347108218272
Upgrade
Market Cap Growth
-95.51%-94.48%-56.68%-50.35%-19.56%-26.50%
Upgrade
Enterprise Value
1-53280169217
Upgrade
Last Close Price
1.030.5110.8125.0050.5068.00
Upgrade
PS Ratio
--42.8634.016618.481714.82
Upgrade
PB Ratio
0.840.342.442.964.164.26
Upgrade
P/TBV Ratio
0.840.342.623.074.274.63
Upgrade
EV/Sales Ratio
--29.6224.975133.741367.86
Upgrade
Debt / Equity Ratio
0.430.380.190.110.090.06
Upgrade
Asset Turnover
--0.030.0600.00
Upgrade
Quick Ratio
3.072.735.256.7111.4116.45
Upgrade
Current Ratio
3.353.015.938.0611.7317.25
Upgrade
Return on Equity (ROE)
-192.85%-180.74%-82.11%-47.12%-40.06%-46.39%
Upgrade
Return on Assets (ROA)
-64.02%-66.77%-42.49%-28.96%-23.37%-27.21%
Upgrade
Return on Capital (ROIC)
-75.19%-75.72%-46.74%-31.38%-24.80%-28.88%
Upgrade
Earnings Yield
-383.29%-934.76%-48.84%-19.36%-10.66%-8.27%
Upgrade
FCF Yield
-231.37%-612.29%-32.99%-18.49%-7.09%-6.40%
Upgrade
Buyback Yield / Dilution
-16.22%-11.98%-0.21%-3.16%-6.75%-35.61%
Upgrade
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q